Hepatitis: HCV virologic response--new nomenclature recommendations.

作者: Stanislas Pol

DOI: 10.1038/NRGASTRO.2012.164

关键词:

摘要: As new therapeutics are emerging for the treatment of patients with HCV, nomenclature defining virologic response is becoming outdated, leading to inconsistencies and confusion. A recent paper has attempted devise a that will be able respond future advances in HCV therapy.

参考文章(10)
Heiner Wedemeyer, Donald M Jensen, Eliot Godofsky, Nina Mani, Jean‐Michel Pawlotsky, Veronica Miller, Definitions/Nomenclature Working Group* of the HCV DrAG (HCV Drug Development Advisory Group), under the auspices of the Forum for Collaborative HIV Research, Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents Hepatology. ,vol. 56, pp. 2398- 2403 ,(2012) , 10.1002/HEP.25888
Bruce R Bacon, Stuart C Gordon, Eric Lawitz, Patrick Marcellin, John M Vierling, Stefan Zeuzem, Fred Poordad, Zachary D Goodman, Heather L Sings, Navdeep Boparai, Margaret Burroughs, Clifford A Brass, Janice K Albrecht, Rafael Esteban, None, Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection The New England Journal of Medicine. ,vol. 364, pp. 1207- 1217 ,(2011) , 10.1056/NEJMOA1009482
John G. McHutchison, Eric J. Lawitz, Mitchell L. Shiffman, Andrew J. Muir, Greg W. Galler, Jonathan McCone, Lisa M. Nyberg, William M. Lee, Reem H. Ghalib, Eugene R. Schiff, Joseph S. Galati, Bruce R. Bacon, Mitchell N. Davis, Pabak Mukhopadhyay, Kenneth Koury, Stephanie Noviello, Lisa D. Pedicone, Clifford A. Brass, Janice K. Albrecht, Mark S. Sulkowski, Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. The New England Journal of Medicine. ,vol. 361, pp. 580- 593 ,(2009) , 10.1056/NEJMOA0808010
Vincent Mallet, Hélène Gilgenkrantz, Jeanne Serpaggi, Virginie Verkarre, Anaïs Vallet-Pichard, Hélène Fontaine, Stanislas Pol, Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C Annals of Internal Medicine. ,vol. 149, pp. 399- 403 ,(2008) , 10.7326/0003-4819-149-6-200809160-00006
John G. McHutchison, Michael P. Manns, Andrew J. Muir, Norah A. Terrault, Ira M. Jacobson, Nezam H. Afdhal, E. Jenny Heathcote, Stefan Zeuzem, Hendrik W. Reesink, Jyotsna Garg, Mohammad Bsharat, Shelley George, Robert S. Kauffman, Nathalie Adda, Adrian M. Di Bisceglie M.D., Telaprevir for previously treated chronic HCV infection. The New England Journal of Medicine. ,vol. 362, pp. 1292- 1303 ,(2010) , 10.1056/NEJMOA0908014
Anna S Lok, David F Gardiner, Eric Lawitz, Claudia Martorell, Gregory T Everson, Reem Ghalib, Robert Reindollar, Vinod Rustgi, Fiona McPhee, Megan Wind-Rotolo, Anna Persson, Kurt Zhu, Dessislava I Dimitrova, Timothy Eley, Tong Guo, Dennis M Grasela, Claudio Pasquinelli, None, Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 The New England Journal of Medicine. ,vol. 366, pp. 216- 224 ,(2012) , 10.1056/NEJMOA1104430
Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko, Adrian M. Di Bisceglie, K. Rajender Reddy, Natalie H. Bzowej, Patrick Marcellin, Andrew J. Muir, Peter Ferenci, Robert Flisiak, Jacob George, Mario Rizzetto, Daniel Shouval, Ricard Sola, Ruben A. Terg, Eric M. Yoshida, Nathalie Adda, Leif Bengtsson, Abdul J. Sankoh, Tara L. Kieffer, Shelley George, Robert S. Kauffman, Stefan Zeuzem, Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection The New England Journal of Medicine. ,vol. 364, pp. 2405- 2416 ,(2011) , 10.1056/NEJMOA1012912
Stefan Zeuzem, Pietro Andreone, Stanislas Pol, Eric Lawitz, Moises Diago, Stuart Roberts, Roberto Focaccia, Zobair Younossi, Graham R Foster, Andrzej Horban, Peter Ferenci, Frederik Nevens, Beat Müllhaupt, Paul Pockros, Ruben Terg, Daniel Shouval, Bart Van Hoek, Ola Weiland, Rolf Van Heeswijk, Sandra De Meyer, Don Luo, Griet Boogaerts, Ramon Polo, Gaston Picchio, Maria Beumont, None, Telaprevir for retreatment of HCV infection. The New England Journal of Medicine. ,vol. 364, pp. 2417- 2428 ,(2011) , 10.1056/NEJMOA1013086
Edward J Gane, Stuart K Roberts, Catherine AM Stedman, Peter W Angus, Brett Ritchie, Rob Elston, David Ipe, Peter N Morcos, Linda Baher, Isabel Najera, Tom Chu, Uri Lopatin, M Michelle Berrey, William Bradford, Mark Laughlin, Nancy S Shulman, Patrick F Smith, Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial The Lancet. ,vol. 376, pp. 1467- 1475 ,(2010) , 10.1016/S0140-6736(10)61384-0